Addition of 17-(allylamino)-17-demethoxy-geldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacy

Jeannine Refos; Alieke Vonk; Marian ten Kate; Kimberly Eadie; Henri Verbrugh; Irma Woudenberg; Wendy Laureijssen - van de Sande

doi:10.1371/journal.pone.0180961

Addition of 17-(allylamino)-17-demethoxy-geldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacy

Jeannine Refos
, Alieke Vonk
, Marian ten Kate
, Kimberly Eadie
, Henri Verbrugh
, Irma Woudenberg
, Wendy Laureijssen - van de Sande

Medical Microbiology & Infectious Diseases

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Scopus)

33 Downloads (Pure)

Original language	Undefined/Unknown
Article number	e0180961
Journal	PLoS One (print)
Volume	12
Issue number	7
DOIs	https://doi.org/10.1371/journal.pone.0180961
Publication status	Published - 2017

Research programs

EMC MM-04-28-01

Access to Document

10.1371/journal.pone.0180961

REPUB_101231_OA.pdfFinal published version, 7.38 MB

http://hdl.handle.net/1765/101231

Cite this

Refos, J., Vonk, A., ten Kate, M., Eadie, K., Verbrugh, H., Woudenberg, I., & Laureijssen - van de Sande, W. (2017). Addition of 17-(allylamino)-17-demethoxy-geldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacy. PLoS One (print), 12(7), Article e0180961. https://doi.org/10.1371/journal.pone.0180961

@article{72ebd4798b994956ad2e9591c4dfc100,

title = "Addition of 17-(allylamino)-17-demethoxy-geldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacy",

author = "Jeannine Refos and Alieke Vonk and \{ten Kate\}, Marian and Kimberly Eadie and Henri Verbrugh and Irma Woudenberg and \{Laureijssen - van de Sande\}, Wendy",

year = "2017",

doi = "10.1371/journal.pone.0180961",

language = "Undefined/Unknown",

volume = "12",

journal = "PLoS One (print)",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "7",

}

Refos, J, Vonk, A, ten Kate, M, Eadie, K, Verbrugh, H, Woudenberg, I & Laureijssen - van de Sande, W 2017, 'Addition of 17-(allylamino)-17-demethoxy-geldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacy', PLoS One (print), vol. 12, no. 7, e0180961. https://doi.org/10.1371/journal.pone.0180961

Addition of 17-(allylamino)-17-demethoxy-geldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacy. / Refos, Jeannine; Vonk, Alieke; ten Kate, Marian et al.
In: PLoS One (print), Vol. 12, No. 7, e0180961, 2017.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Addition of 17-(allylamino)-17-demethoxy-geldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacy

AU - Refos, Jeannine

AU - Vonk, Alieke

AU - ten Kate, Marian

AU - Eadie, Kimberly

AU - Verbrugh, Henri

AU - Woudenberg, Irma

AU - Laureijssen - van de Sande, Wendy

PY - 2017

Y1 - 2017

U2 - 10.1371/journal.pone.0180961

DO - 10.1371/journal.pone.0180961

M3 - Article

C2 - 28742113

SN - 1932-6203

VL - 12

JO - PLoS One (print)

JF - PLoS One (print)

IS - 7

M1 - e0180961

ER -

Refos J, Vonk A, ten Kate M, Eadie K, Verbrugh H, Woudenberg I et al. Addition of 17-(allylamino)-17-demethoxy-geldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacy. PLoS One (print). 2017;12(7):e0180961. doi: 10.1371/journal.pone.0180961